Lorazepam
LORAZEPAM ORAL CONCENTRATE USP, 2 mg per mL, CIV
Approved
Approval ID
711b60a3-028d-41d4-aa17-8f976e6df23e
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Aug 11, 2022
Manufacturers
FDA
Pharmaceutical Associates, Inc.
DUNS: 044940096
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Lorazepam
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0121-0770
Application NumberANDA090260
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lorazepam
Product Specifications
Route of AdministrationORAL
Effective DateAugust 11, 2022
FDA Product Classification
INGREDIENTS (1)
LORAZEPAMActive
Quantity: 2 mg in 1 mL
Code: O26FZP769L
Classification: ACTIB